Treatment Breaks for Super Responders: An Update from the GUIDE Study of Guselkumab in Psoriasis
SCALE 2024: Listen as Dr. Joel Cohen Interviews Dr. James Q. Del Rosso on Innovative Therapies
James Del Rosso, DO, FAOCD
Joel L. Cohen, MD, FAAD, FACMS
Pediatric Roundup: Pearls from SDPA Summer Conference 2024
Lisa Swanson, MD, FAAD
Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
Christopher Bunick, MD, PhD
The Little Ones: Perspectives on Pediatric Psoriasis and AD
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying PracticalDermatology… but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.